M&A / Acquisition · Africa · Announced 20 Oct 2026
EastPharma → Sanofi
M&A / Acquisition deal between EastPharma (Turkey) and Sanofi (Egypt), announced 20 Oct 2026.
Parties: EastPharma (East Pharma Ltd) (Turkey) → Sanofi (Egypt)
- Deal type
- M&A / Acquisition
- Value
- Not stated
- Territory
- Cairo, Egypt — acquired as EastPharma's manufacturing and export platform for Africa and the Middle East
- Asset
- Sanofi Cairo pharmaceutical manufacturing facility — full ownership transfer to EastPharma
- Announced
- 20 Oct 2026
Our analysis
Why this matters.
Sanofi is transferring full ownership of its Cairo manufacturing facility to EastPharma — the Istanbul-based generics group behind DEVA Holding — in a signing witnessed by the chairman of the Egyptian Drug Authority himself. Sanofi has operated in Egypt for over 60 years; the Cairo site is among its most established assets in Africa. Its sale is not a retreat — it is a strategic repositioning by both sides, and a marker of how manufacturing value is being redistributed across the region .
The full analysis is free to read with a work email on this page.
Source: Servicio de Información del Estado Su portal a Egipto